Rabbit haemorrhagic disease: an investigation of some properties of the virus and evaluation of an inactivated vaccine.
An inactivated vaccine against rabbit haemorrhagic disease (RHD), developed and tested in our laboratory, is produced commercially by Bioveta, Ivanovice, Czechoslovakia. Rabbits developed full protection against infection 3 weeks after the administration of a single dose. Antibodies were detectable from day 5 after vaccination. Naturally acquired antibodies were demonstrated in some rabbits kept on commercial farms. The virus survived at least 225 days in an organ suspension kept at 4 degrees C, at least 105 days in the dried state on cloth at room temperature (around 20 degrees C), and at least 2 days at 60 degrees C, both in organ suspension and in the dry state. Experimental infection of rabbits younger than 2 months was successful in some animals. Hares, guinea pigs, white mice, golden and Chinese hamsters, chinchillas and hysterectomy-derived, colostrum-deprived piglets were resistant to infection.
Smíd
B
B
Veterinary Research Institute, Brno, Czechoslovakia.
Valícek
L
L
Rodák
L
L
Stĕpánek
J
J
Jurák
E
E
D000367:Age Factors; D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D002139:Caliciviridae / Q000254:growth & development / Q000276:immunology* / Q000648:ultrastructure; D002682:Chinchilla; D006224:Cricetinae; D003412:Cricetulus; D004198:Disease Susceptibility; D006168:Guinea Pigs; D007793:Lagomorpha; D008647:Mesocricetus; D051379:Mice; D008854:Microscopy, Electron; D010850:Picornaviridae Infections / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control / Q000662:veterinary*; D011817:Rabbits; D013045:Species Specificity; D013552:Swine; D013696:Temperature; D015164:Vaccines, Inactivated / Q000276:immunology / Q000592:standards; D014765:Viral Vaccines / Q000276:immunology / Q000592:standards*
D000914:Antibodies, Viral; D015164:Vaccines, Inactivated; D014765:Viral Vaccines